Literature DB >> 20580170

Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009.

Neil A Bryant1, Adam S Rash, Alana L Woodward, Elizabeth Medcalf, Maud Helwegen, Franziska Wohlfender, Fatima Cruz, Claudia Herrmann, Kerstin Borchers, Ashish Tiwari, Thomas M Chambers, J Richard Newton, Jennifer A Mumford, Debra M Elton.   

Abstract

Like other influenza A viruses, equine influenza virus undergoes antigenic drift. It is therefore essential that surveillance is carried out to ensure that recommended strains for inclusion in vaccines are kept up to date. Here we report antigenic and genetic characterisation carried out on equine influenza virus strains isolated in North America and Europe over a 2-year period from 2008 to 2009. Nasopharyngeal swabs were taken from equines showing acute clinical signs and submitted to diagnostic laboratories for testing and virus isolation in eggs. The sequence of the HA1 portion of the viral haemagglutinin was determined for each strain. Where possible, sequence was determined directly from swab material as well as from virus isolated in eggs. In Europe, 20 viruses were isolated from 15 sporadic outbreaks and 5 viruses were isolated from North America. All of the European and North American viruses were characterised as members of the Florida sublineage, with similarity to A/eq/Lincolnshire/1/07 (clade 1) or A/eq/Richmond/1/07 (clade 2). Antigenic characterisation by haemagglutination inhibition assay indicated that the two clades could be readily distinguished and there were also at least seven amino acid differences between them. The selection of vaccine strains for 2010 by the expert surveillance panel have taken these differences into account and it is now recommended that representatives of both Florida clade 1 and clade 2 are included in vaccines.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580170     DOI: 10.1016/j.vetmic.2010.05.040

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  18 in total

1.  Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

Authors:  Alida Ault; Alyse M Zajac; Wing-Pui Kong; J Patrick Gorres; Michael Royals; Chih-Jen Wei; Saran Bao; Zhi-yong Yang; Stephanie E Reedy; Tracy L Sturgill; Allen E Page; Jennifer Donofrio-Newman; Amanda A Adams; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers; Gary J Nabel; Srinivas S Rao
Journal:  Vaccine       Date:  2012-03-23       Impact factor: 3.641

2.  Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus.

Authors:  Pablo R Murcia; James L N Wood; Edward C Holmes
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

3.  Equine Influenza Virus in Asia: Phylogeographic Pattern and Molecular Features Reveal Circulation of an Autochthonous Lineage.

Authors:  Samuel Miño; Laura Mojsiejczuk; Wei Guo; Haili Zhang; Ting Qi; Cheng Du; Xiang Zhang; Jingfei Wang; Rodolfo Campos; Xiaojun Wang
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

4.  Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012).

Authors:  Sarah Gildea; David A Fitzpatrick; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2013-12       Impact factor: 4.380

5.  Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012.

Authors:  Cecilia Olguin Perglione; Sarah Gildea; Agustina Rimondi; Samuel Miño; Aldana Vissani; Mariano Carossino; Ann Cullinane; Maria Barrandeguy
Journal:  Influenza Other Respir Viruses       Date:  2016-01       Impact factor: 4.380

6.  Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.

Authors:  H G W Pouwels; S M A Van de Zande; L J I Horspool; M J H Hoeijmakers
Journal:  Vet Rec       Date:  2014-05-02       Impact factor: 2.695

7.  Voluntary surveillance program for equine influenza virus in the United States from 2010 to 2013.

Authors:  N Pusterla; P H Kass; S Mapes; C Wademan; N Akana; C Barnett; C MacKenzie; W Vaala
Journal:  J Vet Intern Med       Date:  2015-01-14       Impact factor: 3.333

8.  Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.

Authors:  Lawrence S Lamb; Joscelyn Bowersock; Anindya Dasgupta; G Yancey Gillespie; Yun Su; Austin Johnson; H Trent Spencer
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

Review 9.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

Review 10.  The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary.

Authors:  Romain Paillot; Charles M El-Hage
Journal:  Pathogens       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.